Back
Bolt Biotherapeutics Quote, Financials, Valuation and Earnings
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
42
BOLT
Bolt Biotherapeutics
Last Price:
0.63
Seasonality Move:
-38.25%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock marketBolt Biotherapeutics Price Quote
$0.63
+0.01 (+1.27%)
(Updated: September 19, 2024 at 5:45 PM ET)
Bolt Biotherapeutics Key Stats
Sell
42
Bolt Biotherapeutics (BOLT)
is a Sell
Day range:
$0.62 - $0.64
52-week range:
$0.61 - $1.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.12
P/B ratio:
0.28%
Volume:
75.1K
Avg. volume:
127.4K
1-year change:
-43.45%
Market cap:
$23.8M
Revenue:
$7.9M
EPS:
$-1.74
How Much Does Bolt Biotherapeutics Make?
-
How Much Are Bolt Biotherapeutics's Sales Annually?
BOLT Revenues are $7.9M -
How Much Profit Does Bolt Biotherapeutics's Make A Year?
BOLT net income is -$69.2M
Is Bolt Biotherapeutics Growing As A Company?
-
What Is Bolt Biotherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.11% -
What Is Bolt Biotherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Bolt Biotherapeutics Stock Price Performance
-
Did Bolt Biotherapeutics Stock Go Up Last Month?
Bolt Biotherapeutics share price went down by -10.35% last month -
Did BOLT's Share Price Rise Over The Last Year?
BOLT share price fell by -43.45% over the past 1 year
What Is Bolt Biotherapeutics 52-Week High & Low?
-
What Is Bolt Biotherapeutics’s 52-Week High Share Price?
Bolt Biotherapeutics has traded as high as $1.56 over the past 52 weeks -
What Is Bolt Biotherapeutics’s 52-Week Low Share Price?
Bolt Biotherapeutics has traded as low as $0.61 over the past 52 weeks
Bolt Biotherapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Bolt Biotherapeutics?
-
How Much Debt Does Bolt Biotherapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Bolt Biotherapeutics Have?
Cash and short term investments quarterly total is $73.7M -
What Is Bolt Biotherapeutics’s Book Value Per Share?
Book value per share is 2.24
Is Bolt Biotherapeutics Cash Flow Positive?
-
What Is BOLT Cash Flow From Operations?
Cash flow from operations (TTM) is -$63.9M -
What Is Bolt Biotherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Bolt Biotherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $56.7M
Bolt Biotherapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
BOLT return on invested capital is -57.72% -
What Is Bolt Biotherapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -41.72% -
What Is BOLT Return On Equity?
ROE is a measure of profitability and is -57.72%
Bolt Biotherapeutics Earnings Date & Stock Price
-
What Is Bolt Biotherapeutics's Stock Price Today?
A single share of BOLT can be purchased today for 0.62 -
What Is Bolt Biotherapeutics’s Stock Symbol?
Bolt Biotherapeutics trades on the nasdaq under the ticker symbol: BOLT -
When Is Bolt Biotherapeutics’s Next Earnings Date?
The next quarterly earnings date for Bolt Biotherapeutics is scheduled on November 8, 2024 -
When Is BOLT's next ex-dividend date?
Bolt Biotherapeutics's next ex-dividend date is August 29, 2014 -
How To Buy Bolt Biotherapeutics Stock?
You can buy Bolt Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bolt Biotherapeutics Competitors
-
Who Are Bolt Biotherapeutics's Competitors?
Below is a list of companies who compete with Bolt Biotherapeutics or are related in some way:
Bolt Biotherapeutics Dividend Yield
-
What Is BOLT Dividend Yield?
Bolt Biotherapeutics’s dividend yield currently is 0% -
What Is Bolt Biotherapeutics’s Payout Ratio?
Bolt Biotherapeutics’s payout ratio is 0% -
When Did Bolt Biotherapeutics Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Bolt Biotherapeutics’s Dividend Per Share?
Bolt Biotherapeutics pays a dividend of $0.00 per share
Bolt Biotherapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 4.55% |
| Revenue: | -11.03% | 43.02% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 1.58 |
| Upside from Last Price: | 154.51% |